Aaron Cowen’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-80,000
Closed -$3.97M 102
2025
Q1
$3.97M Buy
+80,000
New +$4.45M 0.15% 66
2022
Q4
Sell
-79,076
Closed -$3.89M 95
2022
Q3
$3.89M Hold
79,076
0.16% 60
2022
Q2
$4.01M Hold
79,076
0.15% 68
2022
Q1
$3.3M Hold
79,076
0.1% 69
2021
Q4
$6.9M Buy
79,076
+7,815
+11% +$766K 0.13% 68
2021
Q3
$8.64M Buy
71,261
+94
+0.1% +$12.8K 0.15% 68
2021
Q2
$13.8M Buy
71,167
+27,422
+63% +$9.02M 0.21% 71
2021
Q1
$17.8M Buy
+43,745
New +$19.5M 0.26% 62

Other funds holding IRON

Aaron Cowen's IRON Position: Q2 2025 in Review

Aaron Cowen sold out of Disc Medicine (IRON) in Q2 2025, closing a stake of 80,000 shares — an estimated $3.97M sold.

Aaron Cowen first reported a position in IRON in Q1 2021 and held it in 8 quarters. The position peaked at $17.8M in Q1 2021. 151 funds tracked by Wall St. Rank hold IRON as of Q2 2025.

  • Aaron Cowen reported no remaining Disc Medicine position as of Q2 2025 after selling out during the quarter.
  • Aaron Cowen sold 80,000 Disc Medicine shares in Q2 2025, an estimated $3.97M.
  • Aaron Cowen first reported a position in Disc Medicine in Q1 2021 and held it in 8 quarters.
  • Aaron Cowen's Disc Medicine position peaked at $17.8M in Q1 2021.
  • 151 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2025.

Based on Suvretta Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.